Developing Technologies

3M Hollow Microstructured Transdermal System Technology

With the development of Hollow Microstructure Transdermal System (hMTS) technology, 3M has opened up new markets to the benefits of transdermal delivery. hMTS provides a means for enabling our partners to compete effectively in injection markets with a transdermal system.

In addition to microstructures, hMTS leverages 3M core technologies in microreplication, micromolding and drug product development to provide a transdermal drug delivery platform that allows partners to reconsider transdermal delivery for products in their portfolio that generally were not considered compatible with existing transdermal delivery methods.

Based on a purely mechanical device design, the hMTS platform is cutting edge yet still simple and convenient to use. It utilizes a polymeric microstructure array that painlessly penetrates the skin, allowing delivery of the drug formulation during a brief wear period from a reservoir through bores in the microstructures. The reservoir is compatible with existing injectable formulations and filling processes.